Astragaloside IV treatment increased SOD activity and decreased the level of MDA at different time points, suggesting that astragaloside IV attenuated lipid peroxidation and reduced the generation of superoxide anions in cerebral ischemia/reperfusion. Here, SOD1 is linked to brain ischemia.